The Canadian Institute of Health Research has awarded $929,475 to Professor Jo Knight of Lancaster Medical School, [...]

Their aim is to understand how genetic variation can be used to optimize smoking cessation treatment choice using data from nine existing clinical trials with more than 5,000 smokers.

Professor Knight said: "We propose to elucidate genetic sources of variation in the nicotine metabolite ratio (NMR), a biomarker of nicotine metabolism rate which optimizes smoking cessation treatment choice.